Clinical Trial Update: Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma [NA]

View source ↗

Summary

This clinical trial update reports the completion of NCT04920162, a study investigating new predictive markers of the immune response in melanoma and vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Vitiligo

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Melanoma and Vitiligo | NA | Status: COMPLETED